News
Check back the news about Paragonix Technologies
Paragonix Expands Research for Advanced Organ Preservation Clinical Registries
Increased participation in the GUARDIAN-Liver Clinical registry follows in the footsteps of the GUARDIAN-Heart and GUARDIAN-Lung, expanding clinical research in Advanced Organ Preservation CAMBRIDGE, MASSACHUSETTS – July 19, 2022 – Paragonix Technologies, the leading hypothermic organ preservation provider, announced today it expanded enrollment in its GUARDIAN series of clinical registries aimed
Paragonix Technologies Announces Expanded Adoption of their LIVERguard™ System at the 2022 American Transplant Congress
With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant Congress CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022
Paragonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study
GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition to improvement in 1-year survival1,2 CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking research from
Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”
Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research on a variety of organ preservation, transportation and clinical data collection topics. These include data presentations comparing the impact of
Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting
Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research on a variety of organ preservation, transportation and clinical data collection topics. These include data presentations comparing the impact of
Paragonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”
From KMTV News Now Omaha OMAHA, Neb. (KMTV) — Looking at him, you might not know Tim Hagen is one in 7.9 billion. “When they found the cancer, the surgery was July 3rd, 2014, and they cut out 18 inches of my colon,” he shared. The stage IV cancer required